文章:
| Line | Frazier and Mosteller assert that medical research |
| | could be improved by a move toward larger, simpler |
| | clinical trials of medical treatments. Currently, |
| | researchers collect far more background information |
| (5) | on patients than is strictly required for their trials— |
| | substantially more than hospitals collect—thereby |
| | escalating costs of data collection, storage, and |
| | analysis. Although limiting information collection |
| | could increase the risk that researchers will overlook |
| (10) | facts relevant to a study, Frazier and Mosteller |
| | contend that such risk, never entirely eliminable from |
| | research, would still be small in most studies. Only |
| | in research on entirely new treatments are new and |
| | unexpected variables likely to arise. |
| (15) | Frazier and Mosteller propose not only that |
| | researchers limit data collection on individual |
| | patients but also that researchers enroll more |
| | patients in clinical trials, thereby obtaining a more |
| | representative sample of the total population with |
| (20) | the disease under study. Often researchers restrict |
| | study participation to patients who have no ailments |
| | besides those being studied. A treatment judged |
| | successful under these ideal conditions can then be |
| | evaluated under normal conditions. Broadening the |
| (25) | range of trial participants, Frazier and Mosteller |
| | suggest, would enable researchers to evaluate a |
| | treatments efficacy for diverse patients under various |
| | conditions and to evaluate its effectiveness for |
| | different patient subgroups. For example, the value |
| (30) | of a treatment for a progressive disease may vary |
| | according to a patients stage of disease. Patients |
| | ages may also affect a treatments efficacy. |
题目:
The passage is primarily concerned with
选项:
A、identifying two practices in medical research that may affect the accuracy of clinical trials
B、describing aspects of medical research that tend to drive up costs
C、evaluating an analysis of certain shortcomings of current medical research practices
D、describing proposed changes to the ways in which clinical trials are conducted
E、explaining how medical researchers have traditionally conducted clinical trials and how such trials are likely to change
答案:
D